Lyntris Sets $492M IPO Terms: Trive’s Defense-Tech Roll-Up Hits NYSE

Lyntris Inc., the defense-technology holding company assembled by Dallas-based
private-equity firm Trive Capital,
launched the roadshow for its initial public offering with formal terms filed on
August 10, 2026. The company is offering 24,000,000 shares of common stock at an
expected price range of $19.00 to $22.00, targeting gross proceeds of roughly
$492 million at the midpoint and up to $528 million if priced at the top of the range,
before an over-allotment option. Shares are expected to list on the New York Stock
Exchange under the ticker LYNX.
(Amendment No. 2 to Form S-1, SEC EDGAR)

Deal terms at a glance

Term Value
Ticker / Exchange LYNX / NYSE
Price range $19.00 – $22.00
Shares offered 24,000,000
  of which: primary (company) 4,878,049
  of which: selling stockholders 19,121,951
Over-allotment (all from selling stockholders) 3,600,000
Gross proceeds at midpoint ($20.50) ~$492M
Gross proceeds at high end ($22.00) ~$528M (+ ~$79M greenshoe)
Shares outstanding after offering ~115.1M
Implied market cap at midpoint ~$2.36B
Free float sold at IPO 20.8% of post-IPO shares
Trive Capital ownership (pre-IPO) ~69%
SEC file / CIK 333-297657 / 0002132582
Source: Lyntris Inc. Amendment No. 2 to Form S-1 (Registration No. 333-297657), filed with the SEC on August 10, 2026. Market cap and gross-proceeds figures are ECMSource calculations from the disclosed share counts.

The company itself is selling only 4.88 million of the 24 million shares on offer —
roughly $100 million at the midpoint. The remaining 19.12 million shares, plus a
3.6 million-share underwriter over-allotment option, come from Trive Capital
funds. Post-IPO, Trive will remain the anchor shareholder even after distributing
a portion of its holdings pro rata to its LPs on the deal date, per the S-1/A.

What Lyntris actually is: two Trive portfolio companies stitched together

Lyntris is the product of an intentional roll-up. The current company was
incorporated in Delaware on May 1, 2026, after being organized as a limited liability
company on April 6, 2026. Six days later, on May 7, 2026, it consummated the
“Combination” — the merger of two existing Trive portfolio businesses that had
been operating separately under the names Accelint (formerly TCFIV FS LLC) and
Vitesse (formerly TCFII NHT LLC). The two halves plug directly into each other:
Accelint contributes software, data fusion, and mission systems; Vitesse contributes
the RF, microwave, thermal-management, and precision-manufacturing hardware that
those systems actually run on.

According to the S-1/A, the group’s operating subsidiaries include Accelint Data
Fusion, Accelint AI, Accelint Mission Solutions, Accelint Global, Accelint
Intelligent Systems, Accelint Industries, Novium, Spacetime Machine Co.
(d/b/a Spacetime Engineering), Vitesse Systems Parent, Nevada Heat Treating
(d/b/a California Brazing), Sterling Precision, Products Support, and Custom
Microwave. The registrant’s principal office is in Falls Church, Virginia.

Three core missions, one customer profile: the U.S. defense budget

Lyntris organizes revenue around three “high-growth core missions” it sells to
the U.S. Department of Defense — which the company notes has “adopted the
secondary title of the U.S. Department of War” (DoW) in its own disclosures — and
allied nations:

  • Maritime Domain Awareness — sensing, tracking, and communication for
    naval and littoral operations.
  • Air & Missile Defense — components and integrated systems supporting
    detection and interception programs.
  • Space Intelligence, Surveillance, Reconnaissance (ISR) & Resilient
    Communications
    — on-orbit sensors, ground segment, and hardened comms.

The end-customer concentration cuts both ways. Being funded by defense
budgets means the customer does not go away in a recession; it also means the
customer can slow-walk appropriations, cancel or delay awards, or reprioritize
without penalty. The S-1/A calls out precisely these dependencies as
principal risks, including reliance on the DoW, allied nation procurement,
contract cancellation risk, subcontractor and supply-chain exposure, and the
company’s short combined operating history.

The financial picture: growing but loss-making

The Combination happened in May 2026, so full-company comparatives are still
short. But the disclosed segment-level figures rolled into Lyntris show the
economics of a defense hardware-plus-software business scaling into production:

Metric Value Comparable
Revenue (FY 2025) $388.9M $334.0M (FY 2024)  +16.4%
Revenue (H1 2026) $241.0M $179.1M (H1 2025)  +34.6%
Adjusted EBITDA (FY 2025) $62.6M $48.6M (FY 2024)  +28.6%
Adjusted EBITDA Margin (FY 2025) ~16.1%
Adjusted EBITDA (H1 2026) $37.8M $25.3M (H1 2025)
Adjusted EBITDA (LTM to June 30, 2026) $75.1M
Source: Lyntris Amendment No. 2 to Form S-1, MD&A section, filed August 10, 2026. Adjusted EBITDA is a non-GAAP measure defined in the prospectus.

The prospectus is explicit that GAAP results still show net losses, driven by
integration expenses, transaction costs, and the amortization associated with the
Combination. Adjusted EBITDA growth of roughly 29% year on year and H1 2026
revenue growth of 35% are the metrics the underwriters will lead with in
one-on-one meetings.

Valuation math: what investors are being asked to pay

Lyntris implied market cap and LTM EV/EBITDA at each end of the price range Bar chart comparing implied post-IPO market capitalization at the low, midpoint, and high of the price range, alongside implied LTM enterprise-value-to-adjusted-EBITDA multiples on the same axis. Lyntris (LYNX) — Implied market cap and LTM EV/Adj. EBITDA $0.0B $0.6B $1.2B $1.8B $2.4B $2.19B Low ($19) $2.36B Midpoint ($20.50) $2.53B High ($22) ~29x LTM ~31x LTM ~34x LTM Multiples use LTM Adjusted EBITDA of $75.1M (through June 30, 2026); enterprise value approximated as market cap.
Source: ECMSource calculations from Lyntris Amendment No. 2 to Form S-1, filed August 10, 2026. Post-IPO share count of ~115.1M derived from 24,000,000 offered shares = 20.8% of post-IPO shares.

At the midpoint, Lyntris comes public at roughly 31x last-twelve-months
Adjusted EBITDA on an enterprise-value-approximated-as-market-cap basis. That is
a growth-tier multiple — higher than legacy defense primes trade for, but not
unusual for a “defense tech” name pitching itself on software content, ISR, and
integrated missile-defense exposure. Once actual debt is disclosed at pricing,
the EV multiple will move higher accordingly.

Underwriters and conflict framework

The book-running managers listed in the Underwriting section of the S-1/A are
Evercore Group L.L.C., Citigroup Global Markets Inc., Guggenheim
Securities, LLC
, and BofA Securities, Inc., with Raymond James &
Associates, Inc.
, Robert W. Baird & Co. Incorporated, and William
Blair & Company, L.L.C.
as additional managers. Evercore has agreed to act as
the qualified independent underwriter for the offering, taking on Section 11
liability under the Securities Act — a role required when one or more underwriters
have a conflict of interest with the issuer under FINRA Rule 5121.
(FINRA Rule 5121)

How this fits the 2026 IPO tape

The Lyntris deal lands into a defense-tech capital-markets window that has
been active on both the public and private side. Just last week, private defense
manufacturer Hadrian
priced a $1.37 billion Series D at a $7.87 billion valuation
, and data-center
developer Switch
filed a confidential IPO targeting an $80 billion return
. The demand pull is
familiar: allied re-armament, a broadening space and ISR budget, and investor
appetite for hardware businesses with recurring software attach. Whether that
demand extends to a Trive-sponsored roll-up with a limited combined operating
history and 69% pre-IPO sponsor ownership is the question the roadshow is designed
to answer.

Key dates and what to watch

  • DRS (confidential draft) filed: July 10, 2026
  • Initial S-1 filed: July 23, 2026
  • S-1 Amendment No. 1: August 3, 2026
  • S-1 Amendment No. 2 (terms): August 10, 2026
  • Expected pricing: not disclosed in the S-1/A; typical NYSE IPO windows
    run one to three weeks after terms are set.

Investors will want the pricing supplement (Form 424B4) for the final
share count, IPO price, use-of-proceeds detail, pro-forma net debt, and lockup
mechanics. Any deviation from the $19–$22 range at pricing will move the market
cap and EV multiples in the chart above proportionally.

Sources

Disclosure: This article is for informational purposes only and is not investment advice.

Leave a Comment